ProCE Banner Activity

Expert Guidance on Monitoring Response to BCR-ABL1 Inhibitors in CML: An Interactive Decision Support Tool

Tool

Use this interactive tool to gain expert guidance on monitoring response to BCR-ABL1 inhibitors in CML, adapting treatment based on response and adverse events, and when to consider treatment-free remission.

Released: January 07, 2025

Expiration: January 06, 2026

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from Bristol Myers Squibb and Novartis Pharmaceuticals Corporation.

Bristol Myers Squibb

Novartis Pharmaceuticals Corporation

Disclosure

Primary Author

Daniel J. DeAngelo, MD, PhD

Professor of Medicine
Harvard Medical School
Chief, Division of Leukemia
Dana-Farber Cancer Institute
Boston, Massachusetts

Daniel J. DeAngelo, MD, PhD: consultant/advisor/speaker: Amgen, Autolos, Blueprint, Gilead, Incyte, Jazz, Novartis, Pfizer, Servier, Takeda; researcher (paid to institution): AbbVie, Blueprint, Glycomimetics, Novartis; data and safety monitoring board: Daiichi Sankyo.

Michael J. Mauro, MD

Director, Chronic Myeloid Leukemia Program
Member, Memorial Sloan Kettering Cancer Center
Professor, Weill Cornell Medicine
New York, New York

Michael J. Mauro, MD: researcher: Enliven, Novartis, Takeda, Terns; consultant/advisor/speaker: Bristol Myers Squibb, Enliven, Novartis, Pfizer, Terns.

Neil P. Shah, MD, PhD

Edward S. Ageno Distinguished Professor in Hematology/Oncology
Director, UCSF Molecular Medicine Residency Program
Chair, National Comprehensive Cancer Network CML Guidelines Panel
University of California, San Francisco
San Francisco, California

Neil P. Shah, MD, PhD: research: Kumquat Biosciences.

B. Douglas Smith, MD

Professor, Oncology
Division of Hematologic Malignancies
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Member of the Miller Coulson Academy of Clinical Excellence
Baltimore, Maryland

B. Douglas Smith, MD: independent contractor: Servier.

Tiffany N. Tanaka, MD

Associate Professor
Division of Blood & Marrow Transplantation
UC San Diego Moores Cancer Center
La Jolla, California

Tiffany N. Tanaka, MD: consultant/advisor/speaker: Bristol Myers Squibb, Gilead, Rigel, Servier.